NYSE:HCA - HCA Healthcare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$136.61 +1.65 (+1.22 %)
(As of 12/13/2018 10:25 AM ET)
Previous Close$134.96
Today's Range$135.50 - $137.62
52-Week Range$84.72 - $147.42
Volume11,657 shs
Average Volume1.79 million shs
Market Capitalization$46.08 billion
P/E Ratio20.72
Dividend Yield1.05%
HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Receive HCA News and Ratings via Email

Sign-up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
Current SymbolNYSE:HCA
Previous Symbol


Debt-to-Equity RatioN/A
Current Ratio1.61
Quick Ratio1.34


Trailing P/E Ratio20.72
Forward P/E Ratio14.63
P/E Growth1.18

Sales & Book Value

Annual Sales$47.65 billion
Price / Sales0.99
Cash Flow$13.3019 per share
Price / Cash Flow10.27
Book Value($14.11) per share
Price / Book-9.68


EPS (Most Recent Fiscal Year)$6.59
Net Income$2.22 billion
Net Margins6.82%
Return on Equity-73.71%
Return on Assets8.51%


Outstanding Shares344,160,000
Market Cap$46.08 billion

HCA Healthcare (NYSE:HCA) Frequently Asked Questions

What is HCA Healthcare's stock symbol?

HCA Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."

How often does HCA Healthcare pay dividends? What is the dividend yield for HCA Healthcare?

HCA Healthcare declared a quarterly dividend on Tuesday, October 30th. Stockholders of record on Monday, December 3rd will be paid a dividend of $0.35 per share on Friday, December 28th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend is Friday, November 30th. View HCA Healthcare's Dividend History.

How were HCA Healthcare's earnings last quarter?

HCA Healthcare Inc (NYSE:HCA) released its quarterly earnings data on Tuesday, October, 30th. The company reported $2.16 EPS for the quarter, topping the Zacks' consensus estimate of $1.93 by $0.23. The company had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm's revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.13 EPS. View HCA Healthcare's Earnings History.

When is HCA Healthcare's next earnings date?

HCA Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, January 29th 2019. View Earnings Estimates for HCA Healthcare.

What guidance has HCA Healthcare issued on next quarter's earnings?

HCA Healthcare issued an update on its FY18 earnings guidance on Tuesday, October, 30th. The company provided EPS guidance of $9.05-9.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.22. The company issued revenue guidance of $46.00-47.00 billion, compared to the consensus revenue estimate of $46.22 billion.

What price target have analysts set for HCA?

21 Wall Street analysts have issued 1 year target prices for HCA Healthcare's shares. Their predictions range from $115.00 to $165.00. On average, they expect HCA Healthcare's stock price to reach $143.7895 in the next year. This suggests a possible upside of 5.1% from the stock's current price. View Analyst Price Targets for HCA Healthcare.

What is the consensus analysts' recommendation for HCA Healthcare?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCA Healthcare in the last year. There are currently 2 sell ratings, 4 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HCA Healthcare.

What are Wall Street analysts saying about HCA Healthcare stock?

Here are some recent quotes from research analysts about HCA Healthcare stock:
  • 1. According to Zacks Investment Research, "HCA Healthcare’s shares have outperformed its industry’s gain in a year’s time.  Its top line has been growing over the last several quarters on higher admissions as well as improved payor and service mix. A number of acquisitions helped the company gain a strong foothold in the industry, fueling its inorganic growth. The company has also raised its guidance from its previous projections. A strong balance sheet and free cash flow are a couple of other positives for the company. However, its high operating expenses continue to weigh on the margins. The company is expected to witness a rise in costs due its constant growth-related investments, which in turn would not allow the debts to reduce, remaining a concern." (12/11/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating and $115 price target, ahead of 2Q18 earnings, which is scheduled for Wednesday, 7/25/18. 1Q18 results featured stronger admissions, higher acuity and better rates, owing to its more complex services and urban setting and we believe that HCA remains the top name to own in the hospital group as it continues to outperform the industry. We expect continued strength going into 2Q18 (see our assumptions in Exhibit 3). There could be a slight M&A drag in 2Q18 due to lower initial margins from recent acquisitions, but we expect it to be temporary and the pickup in acquisitions should accelerate organic growth over the next three or four years, aided by the CMS proposal to boost acute care IPPS payments by 3.4% in 2019." (7/20/2018)

Has HCA Healthcare been receiving favorable news coverage?

News coverage about HCA stock has been trending very positive on Thursday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. HCA Healthcare earned a news impact score of 4.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.

Who are some of HCA Healthcare's key competitors?

Who are HCA Healthcare's key executives?

HCA Healthcare's management team includes the folowing people:
  • Mr. R. Milton Johnson, Chairman & CEO (Age 61)
  • Mr. Samuel N. Hazen, Pres, COO & Director (Age 58)
  • Mr. William B. Rutherford, Exec. VP & CFO (Age 54)
  • Dr. Jonathan B. Perlin, Pres of Clinical Services & Chief Medical Officer (Age 57)
  • Mr. Charles J. Hall, Pres of National Group (Age 65)

Who are HCA Healthcare's major shareholders?

HCA Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.06%), Vanguard Group Inc. (5.79%), Magellan Asset Management Ltd (3.71%), FMR LLC (3.15%), Longview Partners Guernsey LTD (2.72%) and LSV Asset Management (1.58%). Company insiders that own HCA Healthcare stock include Bill B Rutherford, Charles J Hall, Deborah M Reiner, J William Morrow, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Joseph A Sowell III, Kathryn A Torres, Michael S Cuffe, Ravi S Chari, Robert A Waterman, Samuel N Hazen, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Healthcare.

Which major investors are selling HCA Healthcare stock?

HCA stock was sold by a variety of institutional investors in the last quarter, including Sterling Capital Management LLC, American Century Companies Inc., Schroder Investment Management Group, Renaissance Technologies LLC, BlackRock Inc., Mackenzie Financial Corp, Victory Capital Management Inc. and Mitsubishi UFJ Trust & Banking Corp. Company insiders that have sold HCA Healthcare company stock in the last year include Bill B Rutherford, Charles J Hall, Deborah M Reiner, J William Morrow, Jane D Englebright, Jonathan B Perlin, Joseph A Sowell III, Kathryn A Torres, Michael S Cuffe, Ravi S Chari, Samuel N Hazen, Sandra L Morgan and Victor L Campbell. View Insider Buying and Selling for HCA Healthcare.

Which major investors are buying HCA Healthcare stock?

HCA stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, AQR Capital Management LLC, Massachusetts Financial Services Co. MA, Point72 Asset Management L.P., Acadian Asset Management LLC, The Manufacturers Life Insurance Company , Bank of New York Mellon Corp and Bank of Montreal Can. View Insider Buying and Selling for HCA Healthcare.

How do I buy shares of HCA Healthcare?

Shares of HCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HCA Healthcare's stock price today?

One share of HCA stock can currently be purchased for approximately $136.85.

How big of a company is HCA Healthcare?

HCA Healthcare has a market capitalization of $46.08 billion and generates $47.65 billion in revenue each year. The company earns $2.22 billion in net income (profit) each year or $6.59 on an earnings per share basis. HCA Healthcare employs 253,000 workers across the globe.

What is HCA Healthcare's official website?

The official website for HCA Healthcare is http://www.hcahealthcare.com.

How can I contact HCA Healthcare?

HCA Healthcare's mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company can be reached via phone at 615-344-9551 or via email at [email protected]

MarketBeat Community Rating for HCA Healthcare (NYSE HCA)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  897 (Vote Outperform)
Underperform Votes:  393 (Vote Underperform)
Total Votes:  1,290
MarketBeat's community ratings are surveys of what our community members think about HCA Healthcare and other stocks. Vote "Outperform" if you believe HCA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel